Wechselwirkungen · Renvela
Renvela 800 mg film-coated tablets · Abschnitt 4.5 · PDF-Seite 5
HOS-210000 · Präparat HOS-154423
Anti-arrhythmics and anti-seizure medicinal products Patients taking anti-arrhythmic medicinal products for the control of arrhythmias and anti-seizure medicinal products for the control of seizure disorders were excluded from clinical trials. Therefore, possible reduction in absorption cannot be excluded. The anti-arrhythmic medical product should be taken at least one hour before or three hours after Renvela, and blood monitoring can be considered.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-01-08T14:14:00Z · SHA-256 bbf3dc33189cc1d9b3899a8467b5fba24bbecb6d3eee0294a19e6353e199788f · Passage cd5531e7c629a78735d8968a09b31862300fcb7865a835f671321e90c155c0d9 · Zeichen 1337–1791 im Abschnitt